Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd THCBF


Primary Symbol: C.THC

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Post by Ofwoodon Apr 08, 2024 9:43am
203 Views
Post# 35976483

Some news

Some newsFrom last two months fillings https://thecse.com/listings/thc-biomed-intl-ltd/cse-filings/

On March 13, 2024, THC BioMed announced that it has changed its auditor from Baker Tilly WM LLP, Chartered Professional Accountants (the “Former Auditor”) to Davidson & Company LLP, Chartered Professional Accountants (the “Successor Auditor”) effective March 8, 2024. At the request of THC BioMed, the Former Auditor resigned as auditor for THC BioMed effective March 8, 2024, and the board of directors of THC BioMed appointed the Successor Auditor as the replacement auditor for THC BioMed effective March 8, 2024, until THC BioMed’s next annual general meeting.
<< Previous
Bullboard Posts